A PET-CT szerepe diffúz nagy B-sejtes limfómás betegek kezelésében

Translated title of the contribution: The role of PET/CT investigation in the management of patients with diffuse large B-cell lymphoma

Melinda Paksi, J. Demeter, Péter Szabó

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin's lymphoma (NHL). Although this lymphoma is curable, 40% of patients with DLBCL will die of relapsed or refractory disease. 18F-Fluoro-deoxyglucose positron emission tomography (FDG-PET) is a noninvasive, 3-dimensional, functional imaging modality. When combined with the anatomical imaging tool computed tomography (CT), PET/CT can differentiate among others necrotic masses and viable tumors. PET scan has become a basic clinical tool for staging and response assessment in aggressive lymphomas, such as DLBCL. It has been evaluated in pretreatment staging, restaging, monitoring during therapy, post-therapy surveillance and assessment of transformation. Based on the preliminary results of several studies FDG-PET scans play an important role in the early assessment of treatment response, in planning of the treatment including radiation therapy and in the estimation of prognosis.

Original languageHungarian
Pages (from-to)108-117
Number of pages10
JournalMagyar Onkologia
Volume60
Issue number2
Publication statusPublished - Jun 6 2016

Fingerprint

Lymphoma, Large B-Cell, Diffuse
Tomography
Positron-Emission Tomography
Deoxyglucose
Lymphoma
Therapeutics
Non-Hodgkin's Lymphoma
Radiotherapy
Neoplasms

ASJC Scopus subject areas

  • Oncology

Cite this

A PET-CT szerepe diffúz nagy B-sejtes limfómás betegek kezelésében. / Paksi, Melinda; Demeter, J.; Szabó, Péter.

In: Magyar Onkologia, Vol. 60, No. 2, 06.06.2016, p. 108-117.

Research output: Contribution to journalReview article

Paksi, Melinda ; Demeter, J. ; Szabó, Péter. / A PET-CT szerepe diffúz nagy B-sejtes limfómás betegek kezelésében. In: Magyar Onkologia. 2016 ; Vol. 60, No. 2. pp. 108-117.
@article{7f0c1c34ff6942eda066dd7c4e33b717,
title = "A PET-CT szerepe diff{\'u}z nagy B-sejtes limf{\'o}m{\'a}s betegek kezel{\'e}s{\'e}ben",
abstract = "Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin's lymphoma (NHL). Although this lymphoma is curable, 40{\%} of patients with DLBCL will die of relapsed or refractory disease. 18F-Fluoro-deoxyglucose positron emission tomography (FDG-PET) is a noninvasive, 3-dimensional, functional imaging modality. When combined with the anatomical imaging tool computed tomography (CT), PET/CT can differentiate among others necrotic masses and viable tumors. PET scan has become a basic clinical tool for staging and response assessment in aggressive lymphomas, such as DLBCL. It has been evaluated in pretreatment staging, restaging, monitoring during therapy, post-therapy surveillance and assessment of transformation. Based on the preliminary results of several studies FDG-PET scans play an important role in the early assessment of treatment response, in planning of the treatment including radiation therapy and in the estimation of prognosis.",
author = "Melinda Paksi and J. Demeter and P{\'e}ter Szab{\'o}",
year = "2016",
month = "6",
day = "6",
language = "Hungarian",
volume = "60",
pages = "108--117",
journal = "Magyar Onkologia",
issn = "0025-0244",
publisher = "Akademiai Kiado",
number = "2",

}

TY - JOUR

T1 - A PET-CT szerepe diffúz nagy B-sejtes limfómás betegek kezelésében

AU - Paksi, Melinda

AU - Demeter, J.

AU - Szabó, Péter

PY - 2016/6/6

Y1 - 2016/6/6

N2 - Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin's lymphoma (NHL). Although this lymphoma is curable, 40% of patients with DLBCL will die of relapsed or refractory disease. 18F-Fluoro-deoxyglucose positron emission tomography (FDG-PET) is a noninvasive, 3-dimensional, functional imaging modality. When combined with the anatomical imaging tool computed tomography (CT), PET/CT can differentiate among others necrotic masses and viable tumors. PET scan has become a basic clinical tool for staging and response assessment in aggressive lymphomas, such as DLBCL. It has been evaluated in pretreatment staging, restaging, monitoring during therapy, post-therapy surveillance and assessment of transformation. Based on the preliminary results of several studies FDG-PET scans play an important role in the early assessment of treatment response, in planning of the treatment including radiation therapy and in the estimation of prognosis.

AB - Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin's lymphoma (NHL). Although this lymphoma is curable, 40% of patients with DLBCL will die of relapsed or refractory disease. 18F-Fluoro-deoxyglucose positron emission tomography (FDG-PET) is a noninvasive, 3-dimensional, functional imaging modality. When combined with the anatomical imaging tool computed tomography (CT), PET/CT can differentiate among others necrotic masses and viable tumors. PET scan has become a basic clinical tool for staging and response assessment in aggressive lymphomas, such as DLBCL. It has been evaluated in pretreatment staging, restaging, monitoring during therapy, post-therapy surveillance and assessment of transformation. Based on the preliminary results of several studies FDG-PET scans play an important role in the early assessment of treatment response, in planning of the treatment including radiation therapy and in the estimation of prognosis.

UR - http://www.scopus.com/inward/record.url?scp=85056003726&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85056003726&partnerID=8YFLogxK

M3 - Review article

VL - 60

SP - 108

EP - 117

JO - Magyar Onkologia

JF - Magyar Onkologia

SN - 0025-0244

IS - 2

ER -